A systematic review and critical evaluation of the immunology of chronic fatigue syndrome.
Lyall, Marc, Peakman, Mark, Wessely, Simon · Journal of psychosomatic research · 2003 · DOI
Quick Summary
Researchers reviewed all the studies looking at immune system problems in ME/CFS patients to see what patterns emerged. They found that results were mixed and often contradictory—some studies showed low natural killer cells, while others didn't, especially when looking at higher-quality research. The review suggests that how studies are designed and conducted can affect whether certain immune changes are found.
Why It Matters
This systematic review provides a critical, comprehensive evaluation of immune research in ME/CFS, helping clinicians and patients understand the current state of evidence. It highlights the importance of study methodology in interpreting immunological findings and suggests that inconsistent results may reflect research quality differences rather than true biological variation. This work establishes a baseline for understanding what is and isn't reliably known about immune dysfunction in ME/CFS.
Observed Findings
Study quality inversely correlated with findings of low natural killer cell counts
T cell abnormalities were reported across studies independent of methodological quality
Cytokine level abnormalities were reported independent of study quality
Studies ranged widely in methodological rigor and adherence to inclusion criteria
Results varied significantly across different research groups and methodologies
Inferred Conclusions
Methodological quality significantly influences the detection and reporting of certain immunological findings, particularly regarding natural killer cells
T cell and cytokine abnormalities appear more robustly reported and less dependent on study methodology
No unified pattern of immunological dysfunction can be reliably identified from existing literature
Improved methodological standards are needed to determine true immunological associations in CFS
Remaining Questions
What specific methodological factors lead to false-positive findings of low natural killer cells in lower-quality studies?
Why are T cell and cytokine abnormalities reported more consistently across varying study qualities than natural killer cell findings?
What This Study Does Not Prove
This review does not prove that immune dysfunction doesn't exist in ME/CFS—only that available evidence hasn't consistently demonstrated a reliable pattern. The findings do not establish causation or rule out real biological abnormalities; they indicate that study design quality significantly impacts reproducibility. The review cannot determine whether methodologically-improved future studies will reveal consistent immune markers.